Senate hearing on antipsychotic use in nursing homes to be held today

The Senate Special Committee on Aging will hold a hearing today about the use of antipsychotics in nursing homes.

The hearing, titled “Overprescribed: The Human and Taxpayers' Costs of Antipsychotics in Nursing Homes,” is scheduled for 2 p.m. ET, and will be held in the Dirksen Senate Office Building, Washington, D.C.

Sen. Herb Kohl (D-WI) who is the chairman of the committee, has played an active role in investigating proper prescribing practices of antipsychotics in nursing homes. Antipsychotic medications, such as Seroquel, Zyprexa, Risperdal and Abilify, are often administered off-label to treat agitated and aggressive behaviors in dementia care residents.

Panelists at the hearing will be Daniel R. Levinson, Inspector General, U.S. Department of Health and Human Services; Patrick Conway, M.D., director and chief medical officer, Centers for Medicare & Medicaid Services; Jonathan Evans, M.D. president, American Medical Directors Association; Tom Hlavacek, executive director, Alzheimer's Association of Southeast Wisconsin; Toby Edelman, senior policy attorney, Center for Medicare Advocacy; Cheryl Phillips, M.D., senior vice president of advocacy, LeadingAge.

Click here Wednesday for a live stream of the hearing.

More in News

Provider groups protest MedPAC recommendations to reduce therapy caps

Provider groups protest MedPAC recommendations to reduce therapy ...

Resident care would suffer and providers would shoulder a larger burden if Congress acts on the latest recommendations from the Medicare Payment Advisory Commission, advocates for the long-term care sector ...

Tight timeline forces LTC commission to narrow its ambitions, member says

With its report due by the end of September, the Congressional Long-Term Care Commission is setting its sights on what can be accomplished in an "extraordinarily short time-frame," according to member Judith Stein, executive director of the Center for Medicare Advocacy.

HHS proposes rule to improve consistency of long-term care ombudsman programs

The Department of Health and Human Services' Administration on Aging has proposed a rule to create federal guidelines for long-term care ombudsman programs, to create more uniformity and address questions around ombudsman responsibilities, information disclosure, complaint resolution and conflicts of interest.